612 - Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia. - Eldfors, S.; Kuusanmäki, H.; Kontro, M.; Majumder, M.M.; Parsons, A.; Edgren, H.; Pemovska, T.; Kallioniemi, O.; Wennerberg, K.; Gökbuget, N.; Burmeister, T.; Porkka, K.; et al. (European Journal of Cancer, 2016)